Skip to main content
Erschienen in:

22.06.2024 | Global Health Services Research

From Input to Impact: Clinical Significance of Data Quality in the National Cancer Database

verfasst von: Samantha Warwar, MD, MS, Swati Kulkarni, MD, FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2024

Einloggen, um Zugang zu erhalten

Excerpt

The National Cancer Database (NCDB) is a hospital-based cancer registry that collects data from approximately 1500 Commission on Cancer (CoC)-accredited hospitals.1 It collects data for roughly 1.5 million newly diagnosed cancers annually and represents 75 different cancer sites.1 Implemented in 1989, the NCDB serves as a comprehensive source of oncologic data designed to improve cancer care by supporting clinical outcomes research and quality improvement.2,3 As of 2021, more than 1300 publications cite the use of NCDB participant user files.4 A distinctive feature of the NCDB is the availability of treatment data. Compared with the Surveillance, Epidemiology, and End Results (SEER), a population-based program, the NCDB provides more comprehensive information about the type (e.g., surgery, radiation therapy, chemotherapy) and sequence of cancer treatment, which is of increasing importance as more patients receive multimodality therapy for their initial cancer diagnosis. Another distinguishing feature of the NCDB is the shorter interval of time from data abstraction to data availability in the NCDB, which benefits researchers interested in studying treatment trends and patterns over time.2,3
Literatur
2.
Zurück zum Zitat Bilimoria KY, Stewart AK, Winchester DP, et al. The National Cancer Database: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3):683–90.CrossRefPubMedCentral Bilimoria KY, Stewart AK, Winchester DP, et al. The National Cancer Database: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3):683–90.CrossRefPubMedCentral
3.
Zurück zum Zitat Boffa DJ, Rosen JE, Mallin K, et al. Using the National Cancer Database for outcomes research: a review. JAMA Oncol. 2017;3(12):1722–8.CrossRef Boffa DJ, Rosen JE, Mallin K, et al. Using the National Cancer Database for outcomes research: a review. JAMA Oncol. 2017;3(12):1722–8.CrossRef
4.
Zurück zum Zitat Nelson H, Winchester D, McCabe R. The journey from end results to the National Cancer Database. Bull Am Coll Surg. 2022;107. Nelson H, Winchester D, McCabe R. The journey from end results to the National Cancer Database. Bull Am Coll Surg. 2022;107.
5.
Zurück zum Zitat Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10(1):65–71.CrossRef Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10(1):65–71.CrossRef
6.
Zurück zum Zitat Pathak R, Goldberg SB, Canavan M, et al. Association of survival with adjuvant chemotherapy among patients with early-stage non–small cell lung cancer with vs without high-risk clinicopathologic features. JAMA Oncol. 2020;6(11):1741–50.CrossRef Pathak R, Goldberg SB, Canavan M, et al. Association of survival with adjuvant chemotherapy among patients with early-stage non–small cell lung cancer with vs without high-risk clinicopathologic features. JAMA Oncol. 2020;6(11):1741–50.CrossRef
7.
Zurück zum Zitat Landercasper J, Bennie B, Ahmad HF, et al. Opportunities to reduce reoperations and to improve inter-facility profiling after initial breast-conserving surgery for cancer. A report from the NCDB. Eur J Surg Oncol. 2019;45(11):2026–36.CrossRef Landercasper J, Bennie B, Ahmad HF, et al. Opportunities to reduce reoperations and to improve inter-facility profiling after initial breast-conserving surgery for cancer. A report from the NCDB. Eur J Surg Oncol. 2019;45(11):2026–36.CrossRef
8.
Zurück zum Zitat Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness Eur J Cancer. 2009;45(5):756–64.CrossRef Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness Eur J Cancer. 2009;45(5):756–64.CrossRef
9.
Zurück zum Zitat Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer. 2009;45(5):747–55.CrossRef Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer. 2009;45(5):747–55.CrossRef
11.
Zurück zum Zitat U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on 2022 submission data (1999-2020): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; https://www.cdc.gov/cancer/dataviz, released in November 2023. U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on 2022 submission data (1999-2020): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; https://​www.​cdc.​gov/​cancer/​dataviz, released in November 2023.
12.
Zurück zum Zitat Lerro CC, Robbins AS, Phillips JL, et al. Comparison of cases captured in the national cancer data base with those in population-based Central Cancer Registries. Ann Surg Oncol. 2013;20(6):1759–65.CrossRef Lerro CC, Robbins AS, Phillips JL, et al. Comparison of cases captured in the national cancer data base with those in population-based Central Cancer Registries. Ann Surg Oncol. 2013;20(6):1759–65.CrossRef
13.
Zurück zum Zitat Bilimoria KY, Bentrem DJ, Stewart AK, et al. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol. 2009;27(25):4177–81.CrossRef Bilimoria KY, Bentrem DJ, Stewart AK, et al. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol. 2009;27(25):4177–81.CrossRef
Metadaten
Titel
From Input to Impact: Clinical Significance of Data Quality in the National Cancer Database
verfasst von
Samantha Warwar, MD, MS
Swati Kulkarni, MD, FACS
Publikationsdatum
22.06.2024
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2024
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-024-15604-2

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" sprechen Prof. Dr. Leila Harhaus-Wähner und Ressortleiter Dr. Gunter Freese im WebTalk Leitlinie KOMPAKT, einer neuen Webcast-Serie von SpringerMedizin passend zu Ihrem Fachmagazin Orthopädie und Unfallchirurgie Mitteilungen und Nachrichten. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.